These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 34118396)

  • 1. Glymphatic clearance function in patients with cerebral small vessel disease.
    Zhang W; Zhou Y; Wang J; Gong X; Chen Z; Zhang X; Cai J; Chen S; Fang L; Sun J; Lou M
    Neuroimage; 2021 Sep; 238():118257. PubMed ID: 34118396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study.
    Tian Y; Cai X; Zhou Y; Jin A; Wang S; Yang Y; Mei L; Jing J; Li S; Meng X; Wei T; Liu T; Wang Y; Pan Y; Wang Y
    Stroke Vasc Neurol; 2023 Oct; 8(5):413-423. PubMed ID: 37045543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial Stiffness Is Associated With Basal Ganglia Enlarged Perivascular Spaces and Cerebral Small Vessel Disease Load.
    Riba-Llena I; Jiménez-Balado J; Castañé X; Girona A; López-Rueda A; Mundet X; Jarca CI; Álvarez-Sabin J; Montaner J; Delgado P
    Stroke; 2018 May; 49(5):1279-1281. PubMed ID: 29669870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of glymphatic-meningeal lymphatic system with intravenous gadolinium-based contrast-enhancement in cerebral small-vessel disease.
    Zhang M; Tang J; Xia D; Xue Y; Ren X; Huang Q; Shi L; Tang W; Fu J
    Eur Radiol; 2023 Sep; 33(9):6096-6106. PubMed ID: 37410111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer's disease continuum participants.
    Hong H; Hong L; Luo X; Zeng Q; Li K; Wang S; Jiaerken Y; Zhang R; Yu X; Zhang Y; Lei C; Liu Z; Chen Y; Huang P; Zhang M;
    Alzheimers Res Ther; 2024 Feb; 16(1):43. PubMed ID: 38378607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers.
    Hilal S; Ikram MA; Verbeek MM; Franco OH; Stoops E; Vanderstichele H; Niessen WJ; Vernooij MW
    Stroke; 2018 Nov; 49(11):2692-2698. PubMed ID: 30355213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy.
    Xu J; Su Y; Fu J; Wang X; Nguchu BA; Qiu B; Dong Q; Cheng X
    Eur J Neurol; 2022 Oct; 29(10):2895-2904. PubMed ID: 35712978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Between Chronic Obstructive Pulmonary Disease and Cerebral Small Vessel Disease Assessed by Magnetic Resonance Imaging: A Case-Control Study from a Single Center in Beijing, China.
    Qin W; Yin J; Yang L; Yang S; Li Y; Li X; Hu W
    Med Sci Monit; 2020 Nov; 26():e925703. PubMed ID: 33214543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association Between Glymphatic System Dysfunction and Cognitive Impairment in Cerebral Small Vessel Disease.
    Tang J; Zhang M; Liu N; Xue Y; Ren X; Huang Q; Shi L; Fu J
    Front Aging Neurosci; 2022; 14():916633. PubMed ID: 35813943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glymphatic dysfunction mediates the influence of choroid plexus enlargement on information processing speed in patients with white matter hyperintensities.
    Xu Y; Wang M; Li X; Lu T; Wang Y; Zhang X; Wang Z; Yan F
    Cereb Cortex; 2024 Jun; 34(6):. PubMed ID: 38912605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease.
    Chen H; Wan H; Zhang M; Liu G; Wang X; Wang Z; Ma H; Pan Y; Feng T; Wang Y
    Parkinsonism Relat Disord; 2021 Feb; 83():86-92. PubMed ID: 33493785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between remote diffusion-weighted imaging lesions and cerebral small vessel disease in primary intracerebral hemorrhage.
    Xu XH; Ye XH; Li JW; Cai JS; Gao T; Zhang WJ; Zhao GH; Tong LS; Gao F
    Eur J Neurol; 2019 Jul; 26(7):961-968. PubMed ID: 30742740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glymphatic Dysfunction Mediates the Influence of White Matter Hyperintensities on Episodic Memory in Cerebral Small Vessel Disease.
    Ke Z; Mo Y; Li J; Yang D; Huang L; Yang Z; Qin R; Mao C; Lv W; Huang Y; Hu Z; Zhang B; Xu Y
    Brain Sci; 2022 Nov; 12(12):. PubMed ID: 36552071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral small vessel disease: neuroimaging markers and clinical implication.
    Chen X; Wang J; Shan Y; Cai W; Liu S; Hu M; Liao S; Huang X; Zhang B; Wang Y; Lu Z
    J Neurol; 2019 Oct; 266(10):2347-2362. PubMed ID: 30291424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glymphatic pathway in sporadic cerebral small vessel diseases: From bench to bedside.
    Xu J; Su Y; Fu J; Shen Y; Dong Q; Cheng X
    Ageing Res Rev; 2023 Apr; 86():101885. PubMed ID: 36801378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of cerebral small vessel disease load scores in first-ever lacunar infarction.
    Tang R; Liu Z
    Clin Neurol Neurosurg; 2021 Jan; 200():106368. PubMed ID: 33260085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral apolipoprotein is an independent factor for enlarged perivascular space in small vessel disease.
    Zhang W; Wang R; Shi F
    Clin Neurol Neurosurg; 2024 Mar; 238():108185. PubMed ID: 38422746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of Cerebral Small Vessel Disease: Role of the Glymphatic System Dysfunction.
    Lee DH; Lee EC; Park SW; Lee JY; Lee MR; Oh JS
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantity and Morphology of Perivascular Spaces: Associations With Vascular Risk Factors and Cerebral Small Vessel Disease.
    Wang S; Huang P; Zhang R; Hong H; Jiaerken Y; Lian C; Yu X; Luo X; Li K; Zeng Q; Xu X; Yu W; Wu X; Zhang M
    J Magn Reson Imaging; 2021 Oct; 54(4):1326-1336. PubMed ID: 33998738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of perivascular space visualization in basal ganglia and white matter hyperintensity lesion is a meaningful finding for subsequent cognitive decline.
    Sugai Y; Hiraka T; Shibata A; Taketa A; Tanae T; Moriya Y; Ohara S; Iseki C; Ohta Y; Kanoto M
    Acta Radiol; 2024 Jul; 65(7):792-799. PubMed ID: 38841771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.